These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6751703)

  • 1. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
    Svartholm H; Larsson L; Frederiksen B
    Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent treatment of psoriasis with clobetasol propionate.
    Hradil E; Lindström C; Möller H
    Acta Derm Venereol; 1978; 58(4):375-7. PubMed ID: 82342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
    Olsen EA; Cornell RC
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):246-55. PubMed ID: 3528243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
    Telfer NR; Dawber RP
    J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasis treatment: faster clearance when UVB-dithranol is combined with topical clobetasol propionate.
    Lidbrink P; Johannesson A; Hammar H
    Dermatologica; 1986; 172(3):164-8. PubMed ID: 3699218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D; Cornell R; Kamm AR; Bauman WE; Handler RM; Medansky RS; Sturm HM
    Int J Dermatol; 1988; 27(1):54-5. PubMed ID: 3278991
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal suppression following low-dose topical clobetasol propionate.
    Ohman EM; Rogers S; Meenan FO; McKenna TJ
    J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
    Hillström L; Pettersson L; Svensson L
    J Int Med Res; 1982; 10(6):419-22. PubMed ID: 7152080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    Jegasothy BV
    Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
    Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
    Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two application schedules for clobetasol 17 propionate.
    vd Harst LC; de Jonge H; Pot F; Polano MK
    Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate.
    Möller H; Svartholm H; Dahl G
    Curr Med Res Opin; 1983; 8(9):640-4. PubMed ID: 6365465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophic skin striae following the use of clobetasol propionate ointment.
    Hardie RA; Waring AJ; Barnetson RS
    Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with 0.05% clobetasol propionate creams.
    Richards RN
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):891-3. PubMed ID: 4008693
    [No Abstract]   [Full Text] [Related]  

  • 18. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
    Lane PR; Moreland AA; Hogan DJ
    Arch Dermatol; 1990 Sep; 126(9):1211-3. PubMed ID: 2396838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent application of clobetasol-17-propionate in psoriasis.
    Young E; van der Velde EA
    Curr Med Res Opin; 1987; 10(7):468-73. PubMed ID: 3621992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.